Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Bridge Labs Lands $18 Million in New Funding

publication date: Jan 17, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Bridge Laboratories closed $18 million in a third round funding, raising the total of VC money raised by the company to $57 million. Bridge said the money will go to expand its Beijing toxicology lab space. Bridge said the money may also be used to make acquisitions, though it did not say whether those companies would be in the US or China. The investors include the previous investors in the Series B round and several new global investors, including Granite Global Ventures (GGV). More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors